12:00 AM
 | 
Jun 28, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Takeda sales and marketing update

Takeda's Takeda Pharmaceuticals North America Inc. subsidiary launched ACTOplus met XR extended-release pioglitazone/metformin tablets in the U.S. to treat Type II...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >